Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cambria Pharmaceuticals Inc.

www.cambriapharma.com

Latest From BioSource International Inc.

Deal Statistics Quarterly, Q3 2005

In this issue, we present another installment of our quarterly review of dealmaking for July-September 2005. Our data comes from Windhover's Strategic Intelligence Systems, which covers deal activity within the pharmaceutical/biotechnology, medical device, and in vitro diagnostics industries
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Cambria Biosicences LLC
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Cambria Pharmaceuticals Inc.
  • Senior Management
  • Leo Liu, MD, Pres. & CEO
    Donald Kirsch, PhD, SVP, Drug Discovery
  • Contact Info
  • Cambria Pharmaceuticals Inc.
    Phone: (781) 938-1333
    8A Henshaw St.
    Woburn, MA 01801
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register